Morphological Profiling Identifies the Motor Protein Eg5 as Cellular Target of Spirooxindoles

Author:

Liu Jie1,Mallick Shubhadip1,Xie Yusheng1,Grassin Corentin2,Lucas Belén1,Schölermann Beate1,Pahl Axel13,Scheel Rebecca4,Strohmann Carsten4,Protzel Christoph5,Berg Thorsten5,Merten Christian2,Ziegler Slava1,Waldmann Herbert16ORCID

Affiliation:

1. Max Planck Institute of Molecular Physiology Department of Chemical Biology Otto-Hahn-Street 11 44227 Dortmund Germany

2. Ruhr University Bochum Faculty of Chemistry and Biochemistry Organic Chemistry II University-Street 150 44801 Bochum Germany

3. Compound Management and Screening Center Otto-Hahn-Street 11 44227 Dortmund Germany

4. Technical University Dortmund Faculty of Chemistry, Inorganic Chemistry Otto-Hahn-Street 6 44221 Dortmund Germany

5. Leipzig University Institute of Organic Chemistry Johannisallee 29 04103 Leipzig Germany

6. Technical University Dortmund Faculty of Chemistry, Chemical Biology Otto-Hahn-Street 6 44221 Dortmund Germany

Abstract

AbstractOxindoles and iso‐oxindoles are natural product‐derived scaffolds that provide inspiration for the design and synthesis of novel biologically relevant compound classes. Notably, the spirocyclic connection of oxindoles with iso‐oxindoles has not been explored by nature but promises to provide structurally related compounds endowed with novel bioactivity. Therefore, methods for their efficient synthesis and the conclusive discovery of their cellular targets are highly desirable. We describe a selective RhIII‐catalyzed scaffold‐divergent synthesis of spirooxindole–isooxindoles and spirooxindole–oxindoles from differently protected diazooxindoles and N‐pivaloyloxy aryl amides which includes a functional group‐controlled Lossen rearrangement as key step. Unbiased morphological profiling of a corresponding compound collection in the Cell Painting assay efficiently identified the mitotic kinesin Eg5 as the cellular target of the spirooxindoles, defining a unique Eg5 inhibitor chemotype.

Funder

Max-Planck-Gesellschaft

European Commission

Publisher

Wiley

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3